Literature DB >> 10859485

Somatostatin and substance P induced in vivo by lipopolysaccharide and in peritoneal macrophages stimulated with lipopolysaccharide or interferon-gamma have differential effects on murine cytokine production.

S Y Ryu1, K S Jeong, W K Yoon, S J Park, B N Kang, S H Kim, B K Park, S W Cho.   

Abstract

We have investigated whether lipopolysaccharide (LPS) induces substance P (SP) and somatostatin (SOM) in popliteal lymph nodes in vivo and whether macrophages are a source of SP and SOM in vitro. We have also investigated the effect of SP and SOM treatment on the production of cytokines. SP reached a maximum 3 days after injection of LPS (100 microg/footpad) and then declined. SOM expression after LPS injection reached a maximum at 5-7 days. Stimulation of thioglycolate-elicited peritoneal macrophages with LPS (20 microg/ml), recombinant interferon-gamma (rIFN-gamma, 100 U/ml), and LPS plus rIFN-gamma induced SOM and SP. Thioglycolate-elicited, unstimulated peritoneal macrophages also synthesized these peptides. SOM (10(-12)-10(-8) M) significantly inhibited IL-6 and IFN-gamma production, whereas SP at those concentrations enhanced cytokine production by activated lymphocytes and macrophages. These findings suggest that neuropeptides which originate from macrophages and nerve fibers act as immunomodulators to mediate changes in the pattern of cytokine production. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10859485     DOI: 10.1159/000026449

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  8 in total

1.  Substance P is responsible for physiological alterations such as increased chloride ion secretion and glucose malabsorption in cryptosporidiosis.

Authors:  Julio Hernandez; Andrew Lackner; Pyone Aye; Kakali Mukherjee; David J Tweardy; Mary-Ann Mastrangelo; Joel Weinstock; Jeffrey Griffiths; Melinda D'Souza; Shantu Dixit; Prema Robinson
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

2.  Interleukin-12 (IL-12) and IL-23 induction of substance p synthesis in murine T cells and macrophages is subject to IL-10 and transforming growth factor beta regulation.

Authors:  Arthur Blum; Tommy Setiawan; Long Hang; Korynn Stoyanoff; Joel V Weinstock
Journal:  Infect Immun       Date:  2008-05-27       Impact factor: 3.441

Review 3.  Hepatitis C virus infection and thyroid autoimmune disorders: A model of interactions between the host and the environment.

Authors:  Francesca Pastore; Antonio Martocchia; Manuela Stefanelli; Pietro Prunas; Stefania Giordano; Lavinia Toussan; Antonio Devito; Paolo Falaschi
Journal:  World J Hepatol       Date:  2016-01-18

4.  Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis.

Authors:  Prema Robinson; A Clinton White; Dorothy E Lewis; John Thornby; Elliott David; Joel Weinstock
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

5.  Effects of somatostatin and octreotide on cytokine and chemokine production by lipopolysaccharide-activated peripheral blood mononuclear cells.

Authors:  F ter Veld; B Rose; R Mussmann; S Martin; C Herder; K Kempf
Journal:  J Endocrinol Invest       Date:  2009-02       Impact factor: 4.256

Review 6.  The interplay of helminthic neuropeptides and proteases in parasite survival and host immunomodulation.

Authors:  Rimanpreet Kaur; Naina Arora; Meera G Nair; Amit Prasad
Journal:  Biochem Soc Trans       Date:  2022-02-28       Impact factor: 4.919

7.  Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental study.

Authors:  Janny C de Grauw; Chris H A van de Lest; Paul René van Weeren
Journal:  Arthritis Res Ther       Date:  2009-03-09       Impact factor: 5.156

8.  Allatostatin C modulates nociception and immunity in Drosophila.

Authors:  Nathaniel D Bachtel; Gary A Hovsepian; Douglas F Nixon; Ioannis Eleftherianos
Journal:  Sci Rep       Date:  2018-05-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.